Alkan, A. Et Al. 2024. Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer. Journal of Cancer Research and Therapeutics , vol.20, no.3 , 913-917.

Alkan, A., Mizrak, D., Yaşar, A., Karci, E., KÖKSOY, E. B., Ürün, M., ... Özyurt, N.(2024). Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer. Journal of Cancer Research and Therapeutics , vol.20, no.3, 913-917.

Alkan, Ali Et Al. "Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer," Journal of Cancer Research and Therapeutics , vol.20, no.3, 913-917, 2024

Alkan, Ali Et Al. "Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer." Journal of Cancer Research and Therapeutics , vol.20, no.3, pp.913-917, 2024

Alkan, A. Et Al. (2024) . "Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer." Journal of Cancer Research and Therapeutics , vol.20, no.3, pp.913-917.

@article{article, author={Ali Alkan Et Al. }, title={Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer}, journal={Journal of Cancer Research and Therapeutics}, year=2024, pages={913-917} }